Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Treatment options for the management of acute leukaemia relapsing following an allogeneic transplant. Bone Marrow Transplant 2008 Mar;41(5):495-503

Date

10/24/2007

Pubmed ID

17952130

DOI

10.1038/sj.bmt.1705888

Scopus ID

2-s2.0-40749132553 (requires institutional sign-in at Scopus site)   28 Citations

Abstract

The management of acute leukaemia which relapses following an allogeneic stem cell transplant remains a major challenge. In this review we summarize the outcomes of the currently available treatment modalities and discuss emerging novel approaches.

Author List

Shaw BE, Russell NH

Author

Bronwen E. Shaw MBChB, PhD Center Director, Professor in the Medicine department at Medical College of Wisconsin




MESH terms used to index this publication - Major topics in bold

Hematopoietic Stem Cell Transplantation
Humans
Immunotherapy, Adoptive
Leukemia, Myeloid, Acute
Neoplasm, Residual
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Protein Kinase Inhibitors
Recurrence
Transplantation, Homologous